RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 163 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $44,000 | +4.8% | 37,550 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $42,000 | -90.2% | 37,550 | -73.8% | 0.00% | -89.3% |
| Q1 2022 | $429,000 | +725.0% | 143,592 | +845.3% | 0.03% | +64.7% |
| Q1 2021 | $52,000 | -69.8% | 15,190 | -79.0% | 0.02% | -65.3% |
| Q4 2016 | $172,000 | -86.0% | 72,249 | -78.3% | 0.05% | -86.2% |
| Q3 2016 | $1,225,000 | +121.9% | 333,657 | +34.9% | 0.35% | +58.0% |
| Q2 2016 | $552,000 | +101.5% | 247,340 | +87.5% | 0.22% | +117.5% |
| Q1 2016 | $274,000 | +64.1% | 131,889 | +140.0% | 0.10% | +32.1% |
| Q4 2015 | $167,000 | +22.8% | 54,960 | 0.0% | 0.08% | +4.0% |
| Q3 2015 | $136,000 | -22.7% | 54,960 | 0.0% | 0.08% | -22.7% |
| Q2 2015 | $176,000 | -10.2% | 54,960 | 0.0% | 0.10% | -11.0% |
| Q1 2015 | $196,000 | +553.3% | 54,960 | +318.9% | 0.11% | +505.6% |
| Q4 2014 | $30,000 | +20.0% | 13,120 | 0.0% | 0.02% | -5.3% |
| Q3 2014 | $25,000 | -47.9% | 13,120 | 0.0% | 0.02% | -38.7% |
| Q2 2014 | $48,000 | – | 13,120 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
| Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
| Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
| Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
| ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
| SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
| Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
| NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
| Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |